Elevance Health Inc (NYSE: ELV) has experienced a decline in its stock price by -1.05 compared to its previous closing price of 535.92. However, the company has seen a fall of -0.75% in its stock price over the last five trading days. zacks.com reported 2024-06-28 that Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is It Worth Investing in Elevance Health Inc (NYSE: ELV) Right Now?
The price-to-earnings ratio for Elevance Health Inc (NYSE: ELV) is above average at 20.04x. The 36-month beta value for ELV is also noteworthy at 0.85. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ELV is 231.34M, and at present, short sellers hold a 0.99% of that float. The average trading volume of ELV on July 04, 2024 was 1.02M shares.
ELV’s Market Performance
ELV stock saw a decrease of -0.75% in the past week, with a monthly decline of -2.29% and a quarterly a decrease of 4.80%. The volatility ratio for the week is 2.15%, and the volatility levels for the last 30 days are 1.87% for Elevance Health Inc (ELV). The simple moving average for the last 20 days is -1.14% for ELV’s stock, with a simple moving average of 7.42% for the last 200 days.
Analysts’ Opinion of ELV
Many brokerage firms have already submitted their reports for ELV stocks, with Morgan Stanley repeating the rating for ELV by listing it as a “Overweight.” The predicted price for ELV in the upcoming period, according to Morgan Stanley is $643 based on the research report published on June 24, 2024 of the current year 2024.
Robert W. Baird, on the other hand, stated in their research note that they expect to see ELV reach a price target of $649. The rating they have provided for ELV stocks is “Outperform” according to the report published on May 30th, 2024.
Barclays gave a rating of “Overweight” to ELV, setting the target price at $584 in the report published on March 06th of the current year.
ELV Trading at -0.84% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.64% of loss for the given period.
Volatility was left at 1.87%, however, over the last 30 days, the volatility rate increased by 2.15%, as shares sank -1.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.34% lower at present.
During the last 5 trading sessions, ELV fell by -0.74%, which changed the moving average for the period of 200-days by +20.02% in comparison to the 20-day moving average, which settled at $535.90. In addition, Elevance Health Inc saw 12.46% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Norwood Felicia F, who sale 6,199 shares at the price of $532.44 back on Apr 24 ’24. After this action, Norwood Felicia F now owns 27,304 shares of Elevance Health Inc, valued at $3,300,590 using the latest closing price.
Norwood Felicia F, the EVP & President,Gov Health Ben of Elevance Health Inc, sale 14,111 shares at $533.74 during a trade that took place back on Apr 23 ’24, which means that Norwood Felicia F is holding 31,460 shares at $7,531,565 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.9 for the gross margin
The net margin for Elevance Health Inc stands at 0.04. The total capital return value is set at 0.56. Equity return is now at value 16.02, with 5.65 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 0.65. The interest coverage ratio of the stock is 36.39.
Currently, EBITDA for the company is 1.74 billion with net debt to EBITDA at 0.52. When we switch over and look at the enterprise to sales, we see a ratio of 0.84. The receivables turnover for the company is 9.39for trailing twelve months and the total asset turnover is 1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
In summary, Elevance Health Inc (ELV) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
